| SpectraBase Spectrum ID |
Dm5iB8e2Nd2 |
| Name |
Piribedil |
| CAS Registry Number |
3605-01-4 |
| Classification |
Pharmaceutical drug, antiparkinsonian |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
298.142975834 u |
| Formula |
C16H18N4O2 |
| InChI |
InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2 |
| InChIKey |
OQDPVLVUJFGPGQ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
298.346 g/mol |
| Nominal Mass |
298 u |
| Quality |
983 |
| Retention Index |
2585 |
| SMILES |
C12=C(C=CC(=C2)CN2CCN(C=3N=CC=CN3)CC2)OCO1 |
| SPLASH |
splash10-000i-4900000000-b1edbd9b3e4ee43f76c0 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine
2-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)pyrimidine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_010278 |
![Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-](/api/spectrum/Dm5iB8e2Nd2/structure.png?h=300&w=458 "Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-")
